That goes without saying, but do offers ever get made in biotech that are conditional upon a company receiving ODD for a product? That is, could a BP make an offer (and yes, that offer takes us then into a trading halt) that says "we will pay you $X for MPL, but only if you're successful with the ODD in June".
I can't imagine any legal reason why a potential buyer couldn't do so, but am asking if it is ever an occurrence in biotech? Is it something BP would consider doing, or will they ONLY wait until after a confirmed ODD?
Ann: Application for quotation of securities - PAA, page-40
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
17.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $82.69M | |||
| Open | High | Low | Value | Volume |
| 17.0¢ | 17.0¢ | 16.3¢ | $108.2K | 647.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 109170 | 16.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 17.0¢ | 117939 | 4 |
View Market Depth
| Last trade - 16.10pm 17/09/2024 (20 minute delay) ? |
| PAA (ASX) Chart |